Gómez-del Arco Pablo, Maki Kazushige, Georgopoulos Katia
Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.
Mol Cell Biol. 2004 Apr;24(7):2797-807. doi: 10.1128/MCB.24.7.2797-2807.2004.
Ikaros is a key regulator of lymphocyte proliferative responses. Inactivating mutations in Ikaros cause antigen-mediated lymphocyte hyperproliferation and the rapid development of leukemia and lymphoma. Here we show that Ikaros's ability to negatively regulate the G(1)-S transition can be modulated by phosphorylation of a serine/threonine-rich conserved region (p1) in exon 8. Ikaros phosphorylation in p1 is induced during the G(1)-S transition. Mutations that prevent phosphorylation in p1 increase Ikaros's ability to impede cell cycle progression and its affinity for DNA. Casein kinase II, whose increased activity in lymphocytes leads to transformation, is a key player in Ikaros p1 phosphorylation. We thus propose that Ikaros's activity as a regulator of the G(1)-S transition is controlled by phosphorylation in response to signaling events that down-modulate its DNA binding activity.
Ikaro是淋巴细胞增殖反应的关键调节因子。Ikaro的失活突变会导致抗原介导的淋巴细胞过度增殖以及白血病和淋巴瘤的快速发展。在此我们表明,Ikaro负向调节G1期至S期转换的能力可通过外显子8中富含丝氨酸/苏氨酸的保守区域(p1)的磷酸化来调节。p1中的Ikaro磷酸化在G1期至S期转换期间被诱导。阻止p1磷酸化的突变增加了Ikaro阻碍细胞周期进程的能力及其与DNA的亲和力。酪蛋白激酶II在淋巴细胞中的活性增加会导致细胞转化,它是Ikaro p1磷酸化的关键参与者。因此我们提出,作为G1期至S期转换调节因子的Ikaro活性是通过磷酸化来控制的,以响应下调其DNA结合活性的信号事件。